Manages Phase 1 - Phase 3 studies, with demonstrated decision making capabilities Provides medical and scientific expertise to cross-functional BMS colleagues Contributes to and is a key member of a high performing Study Delivery Team (SDT) and may be a member of the Clinical Development Team (CDT) Collaborates with CS and inputs into protocols, providing medical strategic oversight in protocol development (input on inclusion/exclusion and other safety-related clinical considerations) Fulfills GCP and compliance obligations for clinical conduct and maintains all required training Contributes to key Health Authority interactions and advisory board meetings as Clinical Trial Physician Supporting People with Disabilities In collaboration with the Clinical Development Lead, designs and develops clinical plans and protocols with a strong strategic focus based on knowledge of asset/drug, disease area and relevant science in order to meet regulatory and disease strategy targets Provides oversight and medical accountability for a group of studies Leads the analysis of benefit/risk for clinical development protocols in a matrix team environment working with Clinical Scientists Partners with CS to support executional delivery of studies (e.g., site activation, enrollment status, as well as adjudication for protocol violations, significant, non-significant deviations etc.) Identifies and builds relationships with principal investigators. Identifies and cultivates thought leaders in order to gain their inputs on emerging science in drug and biomarker research, disease knowledge, and design of clinical development studies and programs Maintains a strong medical/scientific reputation within the disease area. Has in-depth knowledge of etiology, natural history, diagnosis, and treatment of the disorder. Keeps up-to-date in the disease area by attending scientific conferences and ongoing review of the literature Keeps abreast of development and regulatory issues related to other competitive or relevant compounds in development and how our portfolio fits into the competitive landscape Provides ongoing medical education in partnership with CS to allow for protocol-specific training, supporting the study team, investigators, and others MD required (or x-US equivalent) 3 or more years of Industry experience and/or clinical trials experience is required Ability to communicate and present information clearly in scientific and clinical settings Subspecialty training in applicable therapeutic area desired Expertise in the scientific method to test hypotheses, including statistical design, analysis, and interpretation Knowledge of drug development process Knowledge of the components needed to execute an effective clinical plan and protocols Strong leadership skills with proven ability to lead and work effectively in a team environment Travel Required Domestic and International travel may be required.